|
Status |
Public on Apr 08, 2016 |
Title |
HEXIM1 is induced by DHODH inhibition to suppress melanoma |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
May 08, 2014 |
Last update date |
May 15, 2019 |
Contact name |
Leonard Zon |
E-mail(s) |
zon@enders.tch.harvard.edu
|
Organization name |
Boston Children's Hospital
|
Department |
Oncology/Hematology
|
Street address |
1 Blackfan Circle
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02115 |
Country |
USA |
|
|
Platforms (2) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (12)
|
GSM1382433 |
48h DMSO treated A375 cells replicate a |
GSM1382434 |
48h DMSO treated A375 cells replicate b |
GSM1382435 |
48h Leflunomide treated A375 cells replicate a |
|
This SuperSeries is composed of the following SubSeries: |
GSE57430 |
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] |
GSE57431 |
HEXIM1 is induced by DHODH inhibition to suppress melanoma [ChIP-Seq] |
|
Relations |
BioProject |
PRJNA246457 |